AIP
WVE icon

Ameritas Investment Partners’s Wave Life Sciences WVE Stock Holding History

Ameritas Investment Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.9K Buy
11,436
+2,072
+22% +$27K ﹤0.01% 1795
2025
Q4 		$159K Hold
9,364
– – ﹤0.01% 1395
2025
Q3 		$68.5K Sell
9,364
-2,080
-18% -$16.8K ﹤0.01% 1920
2025
Q2 		$74.4K Buy
11,444
+1,802
+19% +$11.9K ﹤0.01% 1934
2025
Q1 		$77.9K Hold
9,642
– – ﹤0.01% 1864
2024
Q4 		$119K Buy
9,642
+2,308
+31% +$30.8K ﹤0.01% 1653
2024
Q3 		$60.1K Hold
7,334
– – ﹤0.01% 2082
2024
Q2 		$36.6K Hold
7,334
– – ﹤0.01% 2309
2024
Q1 		$45.3K Buy
7,334
+2,451
+50% +$12.3K ﹤0.01% 2199
2023
Q4 		$24.7K Hold
4,883
– – ﹤0.01% 2494
2023
Q3 		$28.1K Hold
4,883
– – ﹤0.01% 2385
2023
Q2 		$17.8K Buy
+4,883
New +$19.7K ﹤0.01% 2622
2022
Q2 		– Sell
-2,106
Closed -$4K – 3252
2022
Q1 		$4K Hold
2,106
– – ﹤0.01% 3011
2021
Q4 		$7K Hold
2,106
– – ﹤0.01% 2996
2021
Q3 		$10K Hold
2,106
– – ﹤0.01% 2946
2021
Q2 		$14K Hold
2,106
– – ﹤0.01% 2875
2021
Q1 		$12K Hold
2,106
– – ﹤0.01% 2789
2020
Q4 		$17K Hold
2,106
– – ﹤0.01% 2563
2020
Q3 		$18K Buy
2,106
+440
+26% +$4.82K ﹤0.01% 2441
2020
Q2 		$17K Hold
1,666
– – ﹤0.01% 2441
2020
Q1 		$16K Hold
1,666
– – ﹤0.01% 2309
2019
Q4 		$13K Hold
1,666
– – ﹤0.01% 2639
2019
Q3 		$34K Hold
1,666
– – ﹤0.01% 2109
2019
Q2 		$43K Hold
1,666
– – ﹤0.01% 2005
2019
Q1 		$65K Buy
1,666
+196
+13% +$7.95K ﹤0.01% 1732
2018
Q4 		$62K Hold
1,470
– – ﹤0.01% 1684
2018
Q3 		$74K Hold
1,470
– – ﹤0.01% 1748
2018
Q2 		$56K Buy
1,470
+427
+41% +$18.4K ﹤0.01% 1919
2018
Q1 		$42K Hold
1,043
– – ﹤0.01% 2012
2017
Q4 		$37K Hold
1,043
– – ﹤0.01% 2098
2017
Q3 		$24K Hold
1,043
– – ﹤0.01% 2337
2017
Q2 		$19K Buy
1,043
+467
+81% +$10.1K ﹤0.01% 2495
2017
Q1 		$16K Buy
+576
New +$16.1K ﹤0.01% 2529

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameritas Investment Partners's WVE Position: Q1 2026 in Review

Ameritas Investment Partners increased its Wave Life Sciences (WVE) stake by 22% in Q1 2026, buying an estimated $27K and bringing the position to 11,436 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Ameritas Investment Partners first reported a position in WVE in Q1 2017 and has held it in 33 quarters since. The position peaked at $159K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Ameritas Investment Partners held 11,436 shares of Wave Life Sciences worth $82.9K as of Q1 2026.
  • Ameritas Investment Partners bought 2,072 Wave Life Sciences shares in Q1 2026, an estimated $27K.
  • Wave Life Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1795 holding.
  • Ameritas Investment Partners first reported a position in Wave Life Sciences in Q1 2017 and has held it in 33 quarters since.
  • Ameritas Investment Partners's Wave Life Sciences position peaked at $159K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.